Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.330
+0.040 (3.10%)
At close: Mar 6, 2026, 4:00 PM EST
1.340
+0.010 (0.75%)
After-hours: Mar 6, 2026, 4:11 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
Developing and Commercializing Novel Therapies for Fibrotic Diseases | | 1.58M | 9.69M | 7.57M | 41.82M | 57.05M | | |
Developing and Commercializing Novel Therapies for Fibrotic Diseases Growth | | -83.69% | 27.91% | -81.89% | -26.70% | - | | |
| | 1.58M | 9.69M | 7.57M | 41.82M | 57.05M | | |
| | -83.69% | 27.91% | -81.89% | -26.70% | - | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
| | 1.58M | 9.69M | 7.57M | 41.82M | 57.05M | | |
United States of America Growth | | -83.69% | 27.91% | -81.89% | -26.70% | - | | |
| | 1.58M | 9.69M | 7.57M | 41.82M | 57.05M | | |
| | -83.69% | 27.91% | -81.89% | -26.70% | - | | |
Source: S&P Global Market Intelligence.
